当前位置: X-MOL 学术Hypertension › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes
Hypertension ( IF 6.9 ) Pub Date : 2024-03-11 , DOI: 10.1161/hypertensionaha.123.22410
Jie Yu 1, 2, 3 , Clare Arnott 1, 2, 4, 5 , Qiang Li 1 , Gian Luca Di Tanna 1 , Maoyi Tian 6 , Liping Huang 1 , Xuejun Yin 1, 7 , Xinyi Zhang 6 , Sallie-Anne Pearson 8 , Darwin R. Labarthe 9 , Paul Elliott 10 , Lijing L. Yan 11, 12 , Bo Zhou 13 , Yangfeng Wu 11, 14 , Bruce Neal 1, 15, 16
Affiliation  

BACKGROUND:The SSaSS (Salt Substitute and Stroke Study) has shown that use of a potassium-enriched salt lowers the risk of stroke, total cardiovascular events, and premature death. The effects on cause-specific cardiac outcomes are reported here.METHODS:SSaSS was an unblinded, cluster-randomised trial assessing the effects of potassium-enriched salt compared with regular salt among 20 995 Chinese adults with established stroke and older age and uncontrolled hypertension. Post hoc efficacy analyses were performed using an intention-to-treat method and a hierarchical Poisson regression model adjusting for clustering to obtain rate ratios and 95% CIs. We assessed acute coronary syndrome, heart failure, arrhythmia, and sudden death.RESULTS:Over a mean 4.74 years follow-up, there were 695 acute coronary syndrome events, 454 heart failure events, 230 arrhythmia events, and 1133 sudden deaths recorded. The rates of events were lower in potassium-enriched salt group for all outcomes but CIs were wide for most: acute coronary syndrome (6.32 versus 7.65 events per 1000 person-years; rate ratio, 0.80 [95% CI, 0.65–0.99]); heart failure (9.14 versus 11.32 events per 1000 person-years; rate ratio, 0.88 [95% CI, 0.60–1.28]); arrhythmia (4.43 versus 6.20 events per 1000 person-years; rate ratio, 0.59 [95% CI, 0.35–0.98]); and sudden death (11.01 versus 11.76 events per 1000 person-years; rate ratio, 0.94 [95% CI, 0.82–1.07]; all P>0.05 with adjustment for multiple comparisons).CONCLUSIONS:These results suggest that use of potassium-enriched salt is more likely to prevent than cause cardiac disease but the post hoc nature of these analyses precludes definitive conclusions.REGISTRATION:URL: https://www.clinicaltrials.gov; Unique identifier: NCT02092090.
更新日期:2024-03-11
down
wechat
bug